Real-World Evidence 2022: a sneak peek interview with Alexander Schacht

Written by ALEXANDER SCHACHT (VERAMED)

Real-world evidence

In the run up to Real-World Evidence Live: Rare Diseases and Innovative Therapies (London, UK; 29–30 June 2022), we’re giving you a preview of what you can experience at the event, which will include the exploration of core themes such as reimbursement, machine learning and patient-first practices. One of our speakers, Alexander Schacht (Veramed, London, UK), has sat down with us to talk about his upcoming talk, ‘Accelerated regulatory approval in 2022 and beyond: managing uncertainty with the impact of Brexit and COVID’, which you can attend on day 2 of Real-World Evidence Live 2022. Alexander is the Executive Vice...

To view this content, please register now for access

It's completely free